Reprogramming to pluripotency after overexpression of OCT4, SOX2, KLF4, and MYC is accompanied by global genomic and epigenomic changes. Histone modification and DNA methylation states in induced pluripotent stem cells (iPSCs) have been shown to be highly similar to embryonic stem cells (ESCs). However, epigenetic differences still exist between iPSCs and ESCs. In particular, aberrant DNA methylation states found in iPSCs are a major concern when using iPSCs in a clinical setting. Thus, it is critical to find factors that regulate DNA methylation states in reprogramming. Here, we found that the miR-29 family is an important epigenetic regulator during human somatic cell reprogramming. Our global DNA methylation and hydroxymethylation analysis shows that DNA demethylation is a major event mediated by miR-29a depletion during early reprogramming, and that iPSCs derived from miR-29a depletion are epigenetically closer to ESCs. Our findings uncover an important miRNA-based approach to generate clinically robust iPSCs.
INTRODUCTION
Overexpression of four transcription factors (OCT4, SOX2, KLF4, and MYC) reprograms differentiated cells to become induced pluripotent stem cells (iPSCs). The global epigenomic changes that accompany reprogramming include histone modification, DNA methylation, expression of non-coding RNAs, and reactivation of the inactive X chromosome (Kim et al., 2014; Papp and Plath, 2013) . iPSCs maintain the genetic composition of donor cells, and thus have been proposed to model human diseases in vitro through differentiation into target cell types. In addition, iPSCs can provide autologous cells for cell replacement therapy (Wu and Hochedlinger, 2011) . However, studies have shown that iPSCs contain localized aberrant epigenetic states compared with human embryonic stem cells (hESCs) despite their high similarity (Bock et al., 2011; Lister et al., 2011) . Understanding the reprogramming mechanisms and developing novel reprogramming technologies to minimize the abnormality of iPSCs are critical for the future use of iPSCs.
Among the epigenetic aberrations of iPSCs, DNA methylation is of particular importance. Previous studies showed that unique de novo differentially methylated (DMR) or hydroxymethylated regions (hDMR) are present in iPSCs compared with hESCs (Lister et al., 2011; Wang et al., 2013) . Furthermore, the retention of the epigenetic memory of donor cell types via cell-type-specific methylation affects the differentiation potential of iPSCs (Kim et al., 2011 ). There are three major enzymes that mediate DNA methylation. De novo DNA methyltransferases (DNMT3A and DNMT3B) are responsible for transferring a methyl moiety from S-adenosyl-methionine to cytosine to make 5-methylcytosine (5mC). DNMT1 together with hemimethylated DNA-binding protein UHRF1 maintain 5-mC during cell-cycle progression (Jones, 2012) . DNA demethylation, on the other hand, is either passive or indirect in mammalian cells. It has been shown to be mediated by enzymes recruited during base or nucleotide excision DNA repair responses, as well as by cytidine deaminases (Wu and Zhang, 2010) . Ten-eleven translocation proteins (TET1, TET2, and TET3) belonging to the family of 2-oxoglutarate-and iron (II)-dependent dioxygenases were also identified as DNA demethylation proteins (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009) . TETs were shown to catalyze the oxidation of 5mC into 5-hydroxymethylcytosine (5hmC) (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009) . TETs further convert 5-hmC to formylcytosine (5fC) and carboxycytosine (5caC), which undergo base excision repair by thymine-DNA glycosylase (TDG) (Ito et al., 2011; Shen and Zhang, 2013) . Whereas 5mC is enriched in promoter regions of silent genes, 5mC in the gene body is positively correlated with gene expression (Ball et al., 2009; Lister et al., 2009) . In contrast, 5hmC in both the promoter and gene body is associated with promoting gene expression (Song et al., 2011) .
MicroRNAs, or miRNAs, are a family of small $22 nt RNAs that regulate gene expression at the mRNA or protein level, and with functional implications in a wide range of biological processes (Bartel, 2004) . miRNAs are extensively studied for their cell-and tissue-specific roles in cancer where they are significant contributors to epigenetic landscaping (Croce, 2009 ). The function of miRNAs was also explored in the context of somatic cell reprogramming. It was found that the miRNA 290-295 cluster is highly expressed in ESCs (Marson et al., 2008) , and could enhance reprogramming efficiency in combination with Oct4, Sox2, and Klf4 (Judson et al., 2009; Nakagawa et al., 2008) . It was also shown that miRNA cluster 302-367 (Anokye-Danso et al., 2011), or the cocktail miR-200c, miR-302, and miR-369 (Miyoshi et al., 2011) alone, could successfully reprogram both human and mouse cells to pluripotency, although efficiency is low (Lu et al., 2012) . A diverse number of miRNA targeting processes such as mesenchymal-epithelial transition, apoptosis, and senescence, have been characterized and shown to modulate reprogramming in combination with the classical transcription factors (Bao et al., 2013) . The miR-29 family, comprising miR-29a, miR-29b1, and miR-29c, is aberrantly expressed in various cancers, plays a role in extracellular matrix (ECM) production and fibrosis, and has also been shown to target DNA methylation enzymes Dnmt3a and Dnmt3b (Fabbri et al., 2007; Roderburg et al., 2011; Suh et al., 2012; Yang et al., 2013) . More recently, with the help of our collaborators and others, we have shown that miR-29a also targets the TET protein family and TDG that convert 5mC to 5hmC and C (Cheng et al., 2013; Yang et al., 2013) . Furthermore, miR-29 levels are high in senescent cells (Martinez et al., 2011) and repressed in the presence of Myc (Chang et al., 2008) . Downregulation of miR-29a also showed some improvement of reprogramming efficiency in mouse fibroblasts, but its role in human reprogramming remains unexplored .
Given the significance of methylation/demethylation during reprogramming, we set out to investigate the function of miR-29a in regulating the iPSC methylome. Although miR-29a was shown to directly regulate both de novo DNA methyltransferases and demethylases, we found that depletion of miR-29a resulted in DNA demethylation in fibroblasts, suggesting that the major targets of miR-29a in somatic cells are DNA demethylases. Interestingly, and in support of our study, miR-29a targets TETs and TDG were recently shown to impair reprogramming of murine fibroblasts when downregulated, due to the block of miRNAmediated mesenchymal-to-epithelial transition that is required for reprogramming (Hu et al., 2014) . More importantly, iPSC lines derived from miR-29a depletion partly overcome the aberrant DNA methylation status observed in control-derived iPSC and resemble hESCs in their methylome. Our study facilitates the understanding of the role of small RNAs in modulating the iPSC epigenome.
RESULTS
The miR-29 Family Regulates Proteins Involved in DNA Methylation Because our previous works and others have shown that iPSCs undergo global DNA methylation/hydroxymethylation changes, we reasoned that miR-29 plays critical roles in regulating epigenetic changes during reprogramming (Doi et al., 2009; Lister et al., 2011) . First, we confirmed the in silico targeting of 3 0 UTRs of DNMTs, TETs, and TDG by miR-29 ( Figure S1 ). Previous studies found that a large number of miRNAs show differences in expression between pluripotent and differentiated cells (Morin et al., 2008; Stadler et al., 2010) . We found that the miR-29 family is highly expressed in the human primary fibroblast line Detroit 551 (D551), but low in human pluripotent cells, including ESCs (H1, H9), iPSCs (BJ-iPSC, PGP1-iPSCs, and D551-iPSCs), and human embryonic carcinoma cells (NCCIT) ( Figure 1A ). Most of its known targets (DNMT3A/3B and TET1/3) involved in DNA methylation show an inverse expression pattern to that of miR-29 expression: low in fibroblasts (D551, MRC-5) and high in pluripotent cells ( Figure S2A ). The luciferase reporter containing the 3 0 UTR of TET1 further confirmed the direct repression by miR-29a ( Figure S2B ). When the reporter was used for unbiased screening to identify miRNAs directly regulating TET1, we found miR-29a and miR-29b were among the miRNAs that most strongly reduced the activity of the reporter (Table S1 ). When examining cells undergoing reprogramming, miR-29 expression decreased while its targets (TET1/3, DNMT3A/B, TDG) increased as the cells became pluripotent ( Figures 1B and S2C) . Furthermore, treating fibroblasts with miR-29a inhibitor increased, while miR-29a mimic decreased total genomic levels of 5hmC, 5fC, and 5caC ( Figure S2D ). Although Guo et al. (2013) reported that miR-29 family expression increased during reprogramming and that miR-29b enhances iPSCs generation in mice, our data showed reduction of miR-29 family expression in humans. In addition, we found that the expression level of miR-29b is significantly lower than the other miR-29 family in fibroblasts ( Figure S2E ), indicating the species difference of miRNAmediated iPSC reprogramming. These data suggest that predicted and known targets of miR-29a may be tightly regulated by this miRNA in pluripotency, reprogramming, and DNA methylation. We employed RNA sequencing (RNA-seq) to examine the global gene expression changes in cells depleted of miR-29. D551 fibroblasts were transfected with miR-29a antagomir or infected with miR-29 sponge, and subsequently used for processing and analysis ( Figure S2F ). miR-29 sponge and miR-29a antagomir similarly affected global gene expression ( Figure 1C ). Genes with predicted miR-29a target sequences at 3 0 UTR were significantly upregulated (Table S2 , p = 4.01 3 10 À33 by hypergeometric test). Gene ontology (GO) analysis showed that ECM genes are highly induced after miR-29a depletion ( Figures 1C and 1D ). The predicted and tested targets of miR-29a, including DNMT3A/B, TETs, and TDG, showed upregulation upon miR-29a depletion, whereas DNMT1 level did not change significantly ( Figures 1E and 1F ). The expression of pluripotency genes OCT4, SOX2, PRDM14,
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miR-29abc sp LIN28A, NANOG, and REX1 were not induced, suggesting no effect in the core pluripotency network by miR-29a depletion (Figures S2G and S2H) . However, KLF4 showed a slight increase after miR-29a depletion, with increasing levels of 5hmC and 5mC in the promoter and gene body, respectively ( Figure S2I ). Because miRNA regulates protein expression via mRNA degradation or translation arrest, we performed proteomics analysis to determine regulation by miR-29a at the protein level. We confirmed that the overall global protein expression is well correlated with the mRNA expression change upon miR-29a depletion ( Figure 1G and Table S3 ). Furthermore, mRNA and protein expression changes increase as the number of target sites on the 3 0 UTR of target genes increases for several seed matches, suggesting that the observed gene expression changes come from the direct regulation by miR-29a (Figure S2J) . Proteomics data identified the DNA methylation regulator TDG as an upregulated protein after miR-29a depletion ( Figure 1G ). Protein levels of other DNA methylation regulators appear to be under the detection limit of this proteomics assay. Taken together, these data suggest that miR-29a regulates the expression of genes involved in DNA methylation regulation.
Depletion of the miR-29 Family Coordinates DNA Methylation and Demethylation
To investigate the effect of miR-29a depletion on DNA methylation regulation, we performed global DNA methylome and hydroxymethylome using methylated and hydroxylmethylated DNA immunoprecipitation sequencing ((h)MeDIP-seq) in D551 cells transfected with miR-29a antagomir. Overall, fibroblasts showed a limited number of 5hmC peaks, in contrast to the large number of 5hmC peaks in human ESCs (Figure 2A ). In addition, only a small number of genes have overlapping hDMRs between miR29a-depleted fibroblasts and ESCs ( Figure S3A ). Surprisingly, we found that miR-29a depletion significantly increased the formation of 5hmC in SOX2 binding sites but not in other reprogramming factor binding sites (Figure S3B ) (Soufi et al., 2012) . Chromatin immunoprecipitation (ChIP)-qPCR analysis revealed that the increasing level of SOX2 binding with 5hmC is caused by miR-29a depletion ( Figure S3C ). These data suggest that changes of the methylation status in SOX2-binding sites upon miR-29a depletion may regulate the binding strength of SOX2 to its targets during early reprogramming. 5mC displayed a more dramatic change after miR-29a depletion. Whereas around 1,000 regions of hyper-differentially methylated regions (hyper-DMRs) were detected, over 7,000 regions of hypo-differentially methylated regions (hypo-DMRs) were observed in miR-29a-depleted cells (Figure 2A) . Interestingly, 92.8% (6,565) of hypoDMRs in miR-29a-depleted cells overlapped with those in human ESCs and are enriched in developmental genes (Figure S3D) , suggesting that miR-29a depletion modulates the fibroblast methylation pattern primarily via DNA demethylation ( Figure 2B ). Changes in gene body methylation were predominant in hyper-and hypo-DMRs for both 5mC and 5hmC ( Figure 2C ). Through GO analysis for the DMRs between control and miR-29a-depleted cells, we found that genes involved in histone modification and development of several lineages have lower 5mC levels in miR-29a-depleted cells compared with controls, reflecting epigenetic dynamics associated with miR-29a modulation ( Figure 2D ). Although promoter methylation marks gene suppression, gene body methylation is highly correlated with gene activation (Ball et al., 2009; Lister et al., 2009 ). Induction of hypo-methylation in the gene body of developmental genes by miR-29a depletion suggests that miR29a depletion represses the developmental genes and thus facilitates the cell fate change. We also found slightly higher 5hmC levels in miR-29a-depleted loci compared with controls, but we could not identify significant GO categories in the loci associated with these 5hmC gains. Interestingly, when we compared the methylation profiles of control versus miR-29a-depleted fibroblasts, many loci resemble the methylation tracks found in the H1 human ESC line ( Figure 2E ). A short 3-day depletion of miR-29a appears to be sufficient to initiate more demethylation in the promoter of the critical pluripotency marker NANOG. Bisulfite sequencing showed that DNA methylation in the NANOG locus was diminished by the miR-29a inhibitor ( Figure S3E , 34%-0%). In contrast, Cadherin 2 (CDH2), a developmental gene not expressed in pluripotent stem cells, gains de novo methylation peaks in its promoter (Figure 2E) (Su et al., 2013) . Our results suggest that one major role of miR-29a in differentiated cells is to maintain the cell fate by DNA methylation.
Next, we transduced fibroblasts individually with virus expressing each DNA methylation-related protein, miR-29 sponge, OSKM, or individual O, S, K, M, and carried out methylation analysis using Illumina's 450K BeadChip. We found a high similarity of methylated (higher ratio to control sample) and demethylated (low ratio to control sample) regions between miR-29 sponge cells and OSKM and TET1/ 2/3 transduced cells ( Figures S3F and S3G ). These data support the idea that the DNA demethylation upon miR-29a depletion has a strong correlation with the regulation by TET family proteins at an early time point in miR-29a-depleted cells, even though the overall pattern is most likely a result of synergistic regulation of all miR-29 targets.
Depletion of the miR-29 Family Contributes to ESCSpecific Transcriptome and Epigenetic Profile in iPSCs
Because depletion of the miR-29a family contributes to the demethylation of fibroblast-specific DNA marks (Figures 2A and 2B) , and a previous report showed that reprogramming of murine somatic cells is improved via miR-29a depletion , we tested whether depletion of miR-29a affects the efficiency of reprogramming in human somatic cells, and whether it influences the epigenetic states in iPSCs. We transfected human fibroblast cells with miR29a antagomir or mimic, or infected them with retrovirus expressing the miR-29 sponge, and subsequently initiated (D) GO analysis of 5mC-and 5hmC-enriched regions specific to control and miR-29ai. Venn diagrams show the number of genes regulated by 5hmC and 5mC in miR-29a depleted and control cells. We did not detect any significant GO terms in genes regulated by 5hmC.
(E) NANOG undergoes demethylation and CDH2 undergoes methylation in miR-29a-depleted cells. These loci become similar to those in human ESCs.
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RelaƟve expression to miR-29a-depleted iPSC miR-29abc sp Figure 3 . Regulation of Reprogramming by miR-29a Inhibition (A) Inhibition of miR-29a using antagomir increases the reprogramming efficiency of human fibroblasts (D551) (n = 6, ***p < 0.003, independent experiments), overexpression using miR-29a mimic decreases reprogramming (n = 6, ***p < 0.005), and sponge-dependent miR-29 inhibition (retrovirus multiplicity of infection = 2.5) increases reprogramming efficiency (n = 3, *p < 0.02, independent (legend continued on next page)
reprogramming. Suppression of miR-29a by either antagomir or sponge increased reprogramming efficiency, whereas overexpression of miR-29a mimic reduced it (Figure 3A) , as assessed by quantifying alkaline-phosphatasestained colonies. We further scored the reprogramming efficiency by staining colonies with pluripotency cell surface marker TRA-160 ( Figure S4A ). The overexpression of TET1 and DNMT3B also significantly increased reprogramming efficiency ( Figures S4B-S4D ), suggesting that positive regulation of reprogramming by depletion of miR-29a may be due to the upregulation of these of DNA methylationrelated proteins. We found that DNMT3B and TET1 display only demethylation ( Figure S3G ), whereas TET2/3 and TDG introduce both methylation and demethylation in developmental genes. Since it was previously reported that miR-29a suppresses p53 , we also tested whether the reprogramming effect by miR-29a involves the p53 pathway. To this end, we reprogrammed human fibroblasts in the presence of miR-29a mimic alone, p53 shRNA alone, or miR-29a mimic + p53 shRNA. We found that reprogramming increases when p53 is depleted, decreases when miR-29a is overexpressed, and does not change in presence of both p53 depletion and miR-29a mimic ( Figure S4E ). This suggests that either p53 is upstream of miR-29a and its depletion is canceling the miRNA effect, or the pathways are separate and their effects annul each other. Next, we asked whether miR-29a depletion plays a role in genetic and epigenetic regulation in reprogramming. We derived human iPSC clones from D551 or fetal myoblast line (FM-1) depleted of miR-29a through antagomir or sponge construct, and performed transcriptome analysis in these iPSC clones. 3D principal component analysis of over 14,000 genes showed closer localization of miR-29a-depleted iPSCs to the H1 and H9 ESC groups than the control counterparts ( Figure 3B ). Furthermore, we observed separate clustering of control and miR-29a-depleted iPSCs independently of parental cell origin (fibroblasts versus myoblasts) and depletion method (antagomir versus sponge) ( Figure 3C ). GO analysis of differentially expressed genes revealed ECM organization genes overrepresented in miR-29a-depleted iPSCs, as expected due to many miR-29a targets falling under this category ( Figure 3C ). Interestingly, neuronal lineage regulators and the WNT pathway are also enriched networks in miR-29a-depleted cells, suggesting both an increase in the pluripotent program pathways (WNT) and modulation of the differentiation potential (neuronal/glial) of the iPSCs by this miRNA, despite the non-neuronal cell of origin. Our group and others have compared gene expression changes between human ESCs and iPSCs and identified aberrantly expressed genes in iPSCs (Huang et al., 2014; Lister et al., 2011; Ruiz et al., 2012; Tanaka et al., 2013; Wang et al., 2013) . We found that most iPSC lines derived under miR-29a-depleted conditions showed suppression of some iPSC-specific genes and recovery of several ESC-specific genes ( Figure 3D ). The most commonly identified ESC-specific genes TCERG1L, FAM19A5, and TMEM132D, and others like ZDHHC19 and HTR6, showed significant recovery in iPSC lines derived from miR-29a depletion ( Figures 3D and  S4F ). Some iPSC-specific genes such as FBP2, CCR8, FAM82A1, MGC16121, and SLC22A2, but not others like ZNF454 and ZNF572, were suppressed in miR-29-depleted cells ( Figures 3E and S4G ). These data suggest that the major effect of miR-29a depletion is demethylation and leads to high similarity with ESC state in hypo-DMRs (Figures 2A  and 2B) .
In order to determine the methylation change in iPSC lines derived from miR-29a depletion, we performed global DNA methylation analysis through MeDIP in ESCs and iPSCs. Surprisingly, we found that iPSC lines with miR-29 depletion cluster with ESC lines for the transcription start sites (TSS), CpG shore, and gene body methylation patterns ( Figure 4A ). CpG island methylation showed no discernible pattern, with the majority of iPSCs clustering separately from ESCs. GO analysis for TSS and gene bodies revealed methylation enrichment in loci involved in metabolic and catabolic processes for ESCs and miR-29-depleted iPSCs compared with control lines (Figures 4B and 4C) . Interestingly, at the CpGI shore level, we found depletion of methylation in loci involved in lineage specification in ESCs and miR-29-depleted iPSCs compared with control experiments). Left: quantification. Right: alkaline phosphatase (AP) staining of two representative wells. Reprogramming with OSKM and miR-29a depletion or overexpression. (B) Principal component analysis shows the similarity of ESCs (H1 and H9) with miR-29a-depleted D551 fibroblasts and iPSCs, and FM-1 fetal-myoblast-derived iPSCs. (C) Left: Differentially expressed genes separating control versus miR-29 knockdown cells irrespective of parental cell of origin (factor loading PC2 < À0.2 and PC3 > 0.2). Right: GO overrepresentation of upregulated genes in miR-29a-depleted iPSCs. The dashed red line denotes FDR = 0.05. (D and E) Average reads per kilobase per million values across all control and miR-29a-depleted iPSCs for (D) genes high in miR-29a-depleted cells and (E) genes high in control iPSCs. ESC-specific genes FAM19A5, TMEM132D, and TCERG1L increased in miR-29-depleted iPSCs (miR29-D denotes miR-29 depletion) (n = 6, 8, 2 in Ctrl iPSC, miR29a-D iPSC, and ESC, respectively, independent experiments). Error bars represent the SD. iPSCs ( Figure 4D ). Gene expression shows significant correlation with methylome changes in TSS, gene body, and CpGI shore, suggesting a functional relevance ( Figure 4E ). Our finding is noteworthy, as DMRs that are present particularly at CpGI shores were distinct between different somatic, cancer, and reprogrammed cell types, possibly acting as cell identity marks (Doi et al., 2009 ).
DISCUSSION
In this study, we set out to investigate the function of miRNAs that regulate the epigenetic landscape in somatic cells and thus may have a function in somatic cell reprogramming. We found that the miR-29 family is highly expressed in somatic cells and decreases in expression during somatic cell reprogramming ( Figures 1A and 1B) . Depletion of miR-29 in fibroblasts dramatically changed the DNA methylation status, suggesting that miR-29a is one of the major miRNAs that maintains the DNA methylation status in fibroblasts (Figure 2 ). Previous studies showed that DNMT3A and DNMT3B, as well as TET proteins, are targets of the miR-29a family (Cheng et al., 2013; Hu et al., 2015) . Our data also demonstrated a strong inverse correlation of the expression of the miR-29a family and the expression of DNMTs and TETs. It is not yet clear which proteins are direct targets of miR-29a in maintaining the DNA methylation status in fibroblasts. However, the global hypo-methylation upon miR-29a depletion suggests that proteins involved in the DNA demethylation including TETs and TDGs may be strong candidate targets (Figures  2A and 2B) .
Previous studies implicated the miR-29a family in mouse somatic cell reprogramming through different pathways Yang et al., 2011) . Yang et al. (2011) showed that suppression of miR-29a via Myc improves the reprogramming by increasing p85alpha and CDC42, thus suppressing the p53 pathway. Guo et al. (2013) demonstrated that Sox2 is a critical factor inducing miR29b, and that ectopic overexpression of miR-29b improves the reprogramming efficiency by suppressing Dnmt3a and Dnmt3b. In reprogramming human somatic cells, we found that suppression of the miR-29a family increased reprogramming efficiency. We also found that overexpression of DNMT3B as well as TET1 improves reprogramming efficiency. These seemingly contrasting results may be due to the bidirectional global epigenetic changes accompanying reprogramming. Not only DNA demethylation but also de novo DNA methylation is found in reprogrammed iPSCs (Lister et al., 2011) . In light of the bidirectional epigenetic regulation, the miR-29a seems to be a unique regulator that potentially suppresses both de novo DNA methyltransferases and demethylases, although miR-29a depletion seems to have a more pronounced effect on DNA demethylation in fibroblasts (Figures 2A and 2B) .
miR-29a depletion could not replace MYC in a three-factor reprogramming attempt (data not shown), although it improves reprogramming moderately but significantly with four-factor reprogramming. MYC is a potent transcription factor inducing and repressing a large number of genes; suppression of miR-29a is one of many functions of MYC during reprogramming . iPSC lines, for which aberrant DNA methylation was reported, were those derived from four-factor reprogramming (Lister et al., 2011) . Most likely, MYC expedites reprogramming independent of its role in suppressing miR-29a. Expression of DNA (de)methylation proteins via suppression of miR29a then becomes supplementary to the function of MYC during reprogramming. When miR-29a targets are upregulated at later stages of reprogramming, most loci are already reprogrammed. Thus, the accessibility of TETs or DNMT3A/B to target loci becomes limited, and thus epigenetic reprogramming is limited in four-factorbased reprogramming.
miRNAs are known to regulate the expression of multiple targets via binding to 3 0 UTR. Our finding that the miR-29 family regulates global DNA methylation and demethylation adds another role to the list of common regulatory roles of miRNAs. The miR-29 family was known to regulate ECM proteins in physiological responses, such as systemic sclerosis, hepatic fibrogenesis, and cardiac fibrosis (Hubmacher and Apte, 2013; Kriegel et al., 2012; Zhang et al., 2012) . The ECM proteins are also important in pluripotent stem cells. Laminin promotes stem cell renewal of ESCs in feeder-free conditions (Xu et al., 2001) , and a mixture of human collagen, fibronectin, and laminin has been used as animal-free culture conditions for ESCs (Ludwig et al., 2006) . Our transcriptome analysis in miR-29a-depleted cells found changes in ECM proteins. Because the process of mesenchymal-epithelial transition and the dynamic changes in ECM proteins are highly coordinated during reprogramming, the miR-29 family seems likely to regulate both the extracellular and intracellular epigenetic responses during reprogramming. iPSC lines derived by miR-29a depletion showed a similar DNA methylation status to that of ESCs (Figure 4) . TSS, gene body, and CpGI shore revealed the clustering of miR-29a depleted iPSCs with ESCs, suggesting that miR-29a depletion has a global impact on DNA methylation changes. Gene expression showed a high correlation with DNA methylation status ( Figure 4E ). Among the genes that express low in iPSCs compared with ESCs are some subtelomericly located genes such as TCERG1L, TMEM132D, and FAM19A5 (Lister et al., 2011) . We found that the expression these genes, particularly TCERG1L, is partially reactivated by suppressing miR-29a. Investigation of the functional relevance of miR-29a depletion on iPSCs, such as developmental potential or epigenetic memory (Kim et al., 2011) , will be important in demonstrating the utility of regulating miR-29a to derive clinically useful iPSCs.
Taken together, we identified miR-29a as an important epigenetic regulator for somatic cells. The acquisition of proper DNA methylation and hydroxymethylation states in iPSCs is not optimal with current reprogramming methods. We provide evidence that DNA methylation undergoes rapid changes upon miR-29a depletion during progression to pluripotency ( Figure S4H ). We believe that the coordinated regulation of multiple DNA methylation proteins by a miRNA family is a tool that will perfect the epigenetic reprogramming of iPSCs in future clinical utilities.
EXPERIMENTAL PROCEDURES
Cell Culture, Reprogramming, and Modulation of miR-29 Expression
Normal primary fibroblast D551 were maintained in DMEM high glucose (Gibco) supplemented with 10% fetal bovine serum and penicillin/streptomycin. Human ESCs and iPSCs were cultured on irradiated murine embryonic feeder cells in medium containing DMEM/F12, 20% knockout serum replacement, and 4 ng/ml basic fibroblast growth factor. Reprogramming was carried out using the four human transcription factors OCT4, SOX2, KLF4, and MYC in murine stem cell virus (pMSCV) retrovirus backbone as previously described (Park et al., 2008) . miR-29a mimic and antagomir were purchased from Dharmacon. miR-29 sponge was generated as described before (Cheng et al., 2013) . Transfection was performed using Lipofectamine.
Gene Expression Analysis
Cells were lysed and RNA was isolated using an RNeasy Mini Kit (Qiagen). Reverse transcription was performed using iScript (Bio-Rad) according to the manufacturer's protocol with primer sets in Table S4A .
ChIP, RNA-Seq, hMeDIP-Seq, and Proteomics Three days after infection with pMSCV retrovirus expression reprogramming factors, cells were harvested for ChIP, RNA-seq, hMeDIP-seq, bisulfite sequencing, or proteomics analysis. Total RNA was extracted using a miRNeasy Mini Kit (Qiagen), and used for qRT-PCR and RNA-seq. Genomic DNA was isolated from D551 fibroblasts transfected with control and miR-29a antagomir and processed for MeDIP and hMeDIP. RNA-seq, ChIP, hMeDIPseq, dot blot, and proteomics were performed as described in Supplemental Experimental Procedures. Total reads and mapped reads are listed in Table S4B .
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